Erika Salvi
Erika Salvi
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Zoltán Kutalik
Zoltán Kutalik
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Nicola Glorioso
Nicola Glorioso
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Paola Benaglio
Paola Benaglio
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Francesca Frau
Francesca Frau
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Tatiana Kuznetsova
Tatiana Kuznetsova
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Hisatomi Arima
Hisatomi Arima
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Clive Hoggart
Clive Hoggart
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Jean Tichet
Jean Tichet
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Yury P Nikitin
Yury P Nikitin
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Costanza Conti
Costanza Conti
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Jitka Seidlerova
Jitka Seidlerova
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Valérie Tikhonoff
Valérie Tikhonoff
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Katarzyna Stolarz-Skrzypek
Katarzyna Stolarz-Skrzypek
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Toby Johnson
Toby Johnson
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Nabila Devos
Nabila Devos
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Laura Zagato
Laura Zagato
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Simonetta Guarrera
Simonetta Guarrera
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Roberta Zaninello
Roberta Zaninello
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Andrea Calabria
Andrea Calabria
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Benedetta Stancanelli
Benedetta Stancanelli
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Chiara Troffa
Chiara Troffa
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Lutgarde Thijs
Lutgarde Thijs
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Federica Rizzi
Federica Rizzi
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Galina Simonova
Galina Simonova
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Sara Lupoli
Sara Lupoli
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Giuseppe Argiolas
Giuseppe Argiolas
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Daniele Braga
Daniele Braga
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Maria C D’Alessio
Maria C D’Alessio
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Maria F Ortu
Maria F Ortu
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Fulvio Ricceri
Fulvio Ricceri
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Maurizio Mercurio
Maurizio Mercurio
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Patrick Descombes
Patrick Descombes
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Maurizio Marconi
Maurizio Marconi
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
John Chalmers
John Chalmers
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Stephen Harrap
Stephen Harrap
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Jan Filipovsky
Jan Filipovsky
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Murielle Bochud
Murielle Bochud
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Licia Iacoviello
Licia Iacoviello
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Justine Ellis
Justine Ellis
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Alice V Stanton
Alice V Stanton
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Maris Laan
Maris Laan
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Sandosh Padmanabhan
Sandosh Padmanabhan
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Anna F Dominiczak
Anna F Dominiczak
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Nilesh J Samani
Nilesh J Samani
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Olle Melander
Olle Melander
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Xavier Jeunemaitre
Xavier Jeunemaitre
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Paolo Manunta
Paolo Manunta
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Amnon Shabo
Amnon Shabo
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Paolo Vineis
Paolo Vineis
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Francesco P Cappuccio
Francesco P Cappuccio
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Mark J Caulfield
Mark J Caulfield
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Giuseppe Matullo
Giuseppe Matullo
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Carlo Rivolta
Carlo Rivolta
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Patricia B Munroe
Patricia B Munroe
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Cristina Barlassina
Cristina Barlassina
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Jan A Staessen
Jan A Staessen
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Jacques S Beckmann
Jacques S Beckmann
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1,
Daniele Cusi
Daniele Cusi
1Dept. of Medicine, Surgery and Dentistry, University of Milano. Graduate School of Nephrology, University of Milano, Division of Nephrology, San Paolo Hospital, Milano, Italy (E.S., F.F., A.C., S.L., C.B., D.C.); Filarete Foundation, Genomic and Bioinformatics Unit, Milano (E.S., F.F, A.C., S.L., C.B., D.C.); Department of Medical Genetics, University of Lausanne, Switzerland (Z.K. , P.B., C.R, J.S.B).; Swiss Institute of Bioinformatics, Lausanne, Switzerland (Z.K.); Hypertension and Related Diseases Centre-AOU, University of Sassari, Italy (N.G., R.Z., C.T., G.A., M.F.O.); Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium (T.K., L.T., J.A.S.); The George Institute for Global Health, University of Sydney and the Royal Prince Alfred Hospital (H.A., J.C.); Department of Epidemiology and Biostatistics, School of Public Health, Imperial College of London, London, United Kingdom ( C.H., P.V.); IRSA, Institut inter Régional pour la Santé, Tours, France (J.T.); Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences – Novosibirsk – Russian Federation (Y.P.N., G.S.); I.M.S., Milano, Italy (C.C., M.C.D.); 2nd Department of Internal Medicine, Charles University, Medical, Faculty, Pilsen, Czech Republic (J.S.); University of Padova, Department of Clinical and Experimental Medicine, Padova, Italy (V.T.); First Department of Cardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland (K.S-S.); Clinical Pharmacology and The Genome Centre, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK (T.J., M.J.C., P.B.M.); INSERM, UMRS-970, PARCC, Paris France (N.D., X.J.); Chair of Nephrology, Università Vita Salute San Raffaele; Nephrology, Dialysis and Hypertension Unit, San Raffaele Scientific Institute, Milan, Italy (L.Z., P.M.); Human Genetics Foundation (HUGEF), Turin, Italy (S.G., P.V.); Department of Medicine, University of Catania, Italy (B.S.); KOS Genetic, Milano, Italy (F.R., D.G., M.M.); Department of Genetics, Biology and Biochemistry, University of Torino and Human Genetics Foundation (HUGEF) (F.R., G.M.); Genomics Platform, NCCR "Frontiers in Genetics" CMU University of Geneva Switzerland (P.D.); Center of Transfusion Medicine and Immunohematology, Department of Regenerative Medicine, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano (M.M.), Department of Physiology, University of Melbourne, Melbourne (S.H.); 2nd Medical Department, Cardiology and Angiology, 1st Medical Faculty, Charles University, Prague, Czech Republic (J.F.); Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, 1005 Lausanne, Switzerland (M.B.); Research Laboratories “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy (L.I.); Murdoch Childrens Research Institute, Melbourne, Australia. Department of Physiology, University of Melbourne, Melbourne, Australia (J.E.); Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin 2, Ireland (A.V.S.); Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia (M.L.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (A.F.D., S.P.); BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, G12 8TA, UK (N.J.S.); Department of Cardiovascular Sciences, University of Leicester, Leicester, UK LE3 9QP (N.J.S.); Hypertension and Cardiovascular Disease, Department of Clinical Sciences, Lund University, Malmö Sweden (O.M.); Centre of Emergency Medicine, Skåne University Hospital, Malmö, Sweden (O.M.); University Paris Descartes, Paris France (X.J.); APHP, Department of Genetics, Hopital Europeen Georges Pompidou, Paris France (X.J.); IBM Haifa Research Lab, Haifa Univ. Mount Carmel Haifa, Israel (A.S.); University of Warwick, Warwick Medical School, Coventry, United Kingdom (F.P.C.); Genetic Epidemiology Unit, Department of Epidemiology, Maastricht University, 6200 MD Maastricht, Netherlands (J.A.S.); Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois(CHUV) University Hospital, Lausanne, Switzerland (J.S.B.)
1